Compare
HeartSciences Inc. vs SkyAI, Inc. vs TAO Synergies Inc. vs Z Squared Inc.
| Latest fiscal year | HeartSciences Inc. HSCS | SkyAI, Inc. SKYA | TAO Synergies Inc. TAOX | Z Squared Inc. ZSQR |
|---|---|---|---|---|
| Year ended | 2026-04-30 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $4.3K | $204.1K | $299.1K | $1.36M |
| Revenue growth (YoY) | -0.7% | n/a | n/a | n/a |
| Gross margin | 59.1% | -202.5% | 87.2% (computed) | 86.7% |
| Operating margin | n/m | n/m | n/m | -956.9% |
| Net margin | n/m | n/m | n/m | -874.3% |
| Net income | -$9.14M | -$282.50M | -$28.74M | -$11.92M |
| EPS (Diluted) | n/a | -$11.16 | -$8.81 | -$2.81 |
| Operating cash flow | -$7.43M | -$10.99M | -$6.40M | -$8.60M |
| Free cash flow | -$7.43M | n/a | n/a | n/a |
| Cash & equivalents | $1.70M | $10.38M | $5.50M | n/a |
| Total assets | n/a | $269.08M | $25.84M | $16.15M |
| Total liabilities | n/a | $4.70M | $3.94M | $2.09M |
| Shareholders' equity | $226.1K | $264.38M | $21.05M | $13.56M |
| Return on year-end equity | n/m | -106.9% | -136.5% | -87.9% |
| Shares outstanding | n/a | 29.00M | 7.45M | 5.75M |
Revenue, most recent five fiscal years
| Fiscal year | HeartSciences Inc. | SkyAI, Inc. | TAO Synergies Inc. | Z Squared Inc. |
|---|---|---|---|---|
| Latest | $4.3K Ended 2026-04-30 | $204.1K Ended 2025-12-31 | $299.1K Ended 2025-12-31 | $1.36M Ended 2025-12-31 |
| 1 year earlier | $4.3K Ended 2025-04-30 | n/a | $0 Ended 2024-12-31 | $0 Ended 2024-12-31 |
| 2 years earlier | $18.6K Ended 2024-04-30 | n/a | n/a | $0 Ended 2023-12-31 |
| 3 years earlier | $5.2K Ended 2023-04-30 | n/a | n/a | $0 Ended 2022-12-31 |
| 4 years earlier | $14.4K Ended 2022-04-30 | n/a | n/a | $75.0K Ended 2021-12-31 |